Our study accomplished two important goals, the development of a murine B cell model of EBV disease and the demonstration of improved immune protection against a tumor challenge using a novel LMP-1 peptide antigen delivery system based on the plant virus TMV. The gene discussed is PDLIM7; the disease is neoplasm.